• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography.超越管理式医疗的类型学:以乳腺钼靶筛查的健康计划预测因素为例。
Health Serv Res. 2004 Feb;39(1):179-206. doi: 10.1111/j.1475-6773.2004.00221.x.
2
Effect of cost sharing on screening mammography in Medicare health plans.费用分担对医疗保险健康计划中乳腺钼靶筛查的影响。
N Engl J Med. 2008 Jan 24;358(4):375-83. doi: 10.1056/NEJMsa070929.
3
Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening services.患者成本分担重要吗?其对推荐的与有争议的癌症筛查服务的影响。
Am J Manag Care. 2004 Feb;10(2 Pt 1):99-107.
4
Are gatekeeper requirements associated with cancer screening utilization?守门人要求与癌症筛查的利用率有关吗?
Health Serv Res. 2004 Feb;39(1):153-78. doi: 10.1111/j.1475-6773.2004.00220.x.
5
The effect of area HMO market share on cancer screening.健康维护组织(HMO)在区域市场的份额对癌症筛查的影响。
Health Serv Res. 2004 Dec;39(6 Pt 1):1751-72. doi: 10.1111/j.1475-6773.2004.00316.x.
6
Knowledge, attitudes, and behavior of women ages 65 and older on mammography screening and Medicare: results of a national survey.65岁及以上女性对乳房X光检查和医疗保险的认知、态度及行为:一项全国性调查结果
Women Health. 2002;36(4):1-18. doi: 10.1300/J013v36n04_01.
7
The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative.健康保险作为癌症筛查决定因素的重要性:来自女性健康倡议的证据。
Prev Med. 2000 Sep;31(3):261-70. doi: 10.1006/pmed.2000.0697.
8
Variation in screening mammography and Papanicolaou smear by primary care physician specialty and gatekeeper plan (United States).按初级保健医生专业和把关人计划(美国)划分的乳腺钼靶筛查和巴氏涂片检查差异
Cancer Causes Control. 2004 Nov;15(9):883-92. doi: 10.1007/s10552-004-1138-5.
9
Women's compliance with public health guidelines for mammograms and pap tests in Canada and the United States: an analysis of data from the Joint Canada/United States Survey Of Health.加拿大和美国女性对乳房X光检查和巴氏试验公共卫生指南的遵循情况:对加拿大/美国健康联合调查数据的分析。
Womens Health Issues. 2008 Mar-Apr;18(2):85-99. doi: 10.1016/j.whi.2007.10.006. Epub 2008 Jan 7.
10
Demand response of mental health services to cost sharing under managed care.管理式医疗下心理健康服务对成本分担的需求响应。
J Ment Health Policy Econ. 2008 Sep;11(3):113-25.

引用本文的文献

1
Medicaid Expansions: Probing Medicaid's Filling of the Cancer Genetic Testing and Screening Space.医疗补助计划扩张:探究医疗补助计划在癌症基因检测与筛查领域的填补情况。
Healthcare (Basel). 2022 Jun 8;10(6):1066. doi: 10.3390/healthcare10061066.
2
Impact of GP gatekeeping on quality of care, and health outcomes, use, and expenditure: a systematic review.GP 守门人对医疗质量、健康结果、使用和支出的影响:系统评价。
Br J Gen Pract. 2019 May;69(682):e294-e303. doi: 10.3399/bjgp19X702209. Epub 2019 Mar 25.
3
U.S. Preventive Services Task Force recommendations and cancer screening among female Medicare beneficiaries.美国预防服务工作组的建议与女性 Medicare 受益人的癌症筛查
J Womens Health (Larchmt). 2014 Mar;23(3):211-7. doi: 10.1089/jwh.2013.4421. Epub 2013 Nov 6.
4
Mammography utilization among Black and White Medicare beneficiaries in high breast cancer mortality US counties.美国高乳腺癌死亡率县中,黑人和白人 Medicare 受益人的乳房 X 光检查利用率。
Cancer Causes Control. 2013 Dec;24(12):2187-96. doi: 10.1007/s10552-013-0295-9.
5
Coverage and preventive screening.保险范围和预防筛查。
Health Serv Res. 2011 Feb;46(1 Pt 1):173-84. doi: 10.1111/j.1475-6773.2010.01188.x. Epub 2010 Oct 28.
6
Insurance disruption due to spousal Medicare transitions: implications for access to care and health care utilization for women approaching age 65.配偶医疗保险过渡导致的保险中断:对接近65岁女性获得医疗服务及医疗保健利用的影响。
Health Serv Res. 2009 Jun;44(3):946-64. doi: 10.1111/j.1475-6773.2009.00952.x. Epub 2009 Mar 5.
7
Rates and predictors of colorectal cancer screening.结直肠癌筛查的比率及预测因素。
Prev Chronic Dis. 2006 Oct;3(4):A117. Epub 2006 Sep 15.
8
The effect of area HMO market share on cancer screening.健康维护组织(HMO)在区域市场的份额对癌症筛查的影响。
Health Serv Res. 2004 Dec;39(6 Pt 1):1751-72. doi: 10.1111/j.1475-6773.2004.00316.x.
9
Are gatekeeper requirements associated with cancer screening utilization?守门人要求与癌症筛查的利用率有关吗?
Health Serv Res. 2004 Feb;39(1):153-78. doi: 10.1111/j.1475-6773.2004.00220.x.
10
The challenge of studying the effects of managed care as managed care evolves.随着管理式医疗的发展,研究其效果所面临的挑战。
Health Serv Res. 2004 Feb;39(1):7-12. doi: 10.1111/j.1475-6773.2004.00212.x.

本文引用的文献

1
Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening services.患者成本分担重要吗?其对推荐的与有争议的癌症筛查服务的影响。
Am J Manag Care. 2004 Feb;10(2 Pt 1):99-107.
2
Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States.管理式医疗保险对美国特定族裔预防性医疗服务使用情况的影响。
Med Care. 2002 Sep;40(9):743-51. doi: 10.1097/00005650-200209000-00004.
3
Selection bias in HMOs: a review of the evidence.健康维护组织中的选择偏倚:证据综述。
Med Care Res Rev. 2000 Dec;57(4):405-39. doi: 10.1177/107755870005700402.
4
Wrestling with typology: penetrating the "black box" of managed care by focusing on health care system characteristics.
Med Care Res Rev. 2000;57 Suppl 2:93-115. doi: 10.1177/1077558700057002S06.
5
Measuring the "managedness" and covered benefits of health plans.衡量健康保险计划的“管理程度”和涵盖福利。
Health Serv Res. 2000 Aug;35(3):707-34.
6
The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative.健康保险作为癌症筛查决定因素的重要性:来自女性健康倡议的证据。
Prev Med. 2000 Sep;31(3):261-70. doi: 10.1006/pmed.2000.0697.
7
Reliability and validity of women's recall of mammographic screening.女性对乳腺钼靶筛查回忆的可靠性和有效性。
Aust N Z J Public Health. 2000 Feb;24(1):79-81. doi: 10.1111/j.1467-842x.2000.tb00728.x.
8
Do HMOs make a difference? Use of health services.健康维护组织(HMOs)有作用吗?医疗服务的使用情况。
Inquiry. 1999;36(4):400-10.
9
Use of preventive services by managed care enrollees: an updated perspective.管理式医疗参保者对预防性服务的使用:最新观点。
Health Aff (Millwood). 2000 Jan-Feb;19(1):102-16. doi: 10.1377/hlthaff.19.1.102.
10
Cost-sharing and the utilization of clinical preventive services.费用分担与临床预防服务的利用
Am J Prev Med. 1999 Aug;17(2):127-33. doi: 10.1016/s0749-3797(99)00057-4.

超越管理式医疗的类型学:以乳腺钼靶筛查的健康计划预测因素为例。

Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography.

作者信息

Tye Sherilyn, Phillips Kathryn A, Liang Su-Ying, Haas Jennifer S

机构信息

School of Pharmacy, University of California, San Francisco 94143, USA.

出版信息

Health Serv Res. 2004 Feb;39(1):179-206. doi: 10.1111/j.1475-6773.2004.00221.x.

DOI:10.1111/j.1475-6773.2004.00221.x
PMID:14965083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1361000/
Abstract

OBJECTIVES

To develop a framework of factors to characterize health plans, to identify how plan characteristics were measured in a national survey, and to apply our findings to an analysis of the predictors of screening mammography.

DATA SOURCE

The primary data were from the 1996 Medical Expenditure Panel Survey.

STUDY DESIGN

Women ages 40+, with private insurance, and no history of breast cancer were included in the study (N = 2,909). We used multivariate logistic regression to estimate mammography utilization in the past two years relative to health plan and demographic factors. Health plan measures included whether there is a defined provider network, whether coverage is restricted to a network, use of gatekeepers, level of cost containment, copayment and deductible amounts, coinsurance rate, and breadth of benefit coverage.

PRINCIPAL FINDINGS

We found no significant difference in reported mammography utilization using a dichotomous comparison of individuals enrolled in managed care versus indemnity plans. However, women in health plans with a defined provider network were more likely to report having received a mammogram in the past two years than those without networks (adjusted OR= 1.21, 95 percent CI = 1.07-1.36), and women in gatekeeper plans were more likely to report receiving mammography than those without gatekeepers (adjusted OR = 1.18, 95 percent CI = 1.03-1.36). Restricted out-of-network coverage, use of cost containment, enrollee cost sharing, and breadth of benefit coverage did not appear to affect mammography use.

CONCLUSIONS

It is important to examine the effect of individual health plan components on the utilization of health care, rather than use the traditional broader categorizations of managed versus nonmanaged care or simple health plan typologies.

摘要

目标

构建一个用于描述健康计划的因素框架,确定在一项全国性调查中如何衡量计划特征,并将我们的研究结果应用于分析乳腺钼靶筛查的预测因素。

数据来源

主要数据来自1996年医疗支出小组调查。

研究设计

研究纳入了年龄在40岁及以上、拥有私人保险且无乳腺癌病史的女性(N = 2909)。我们使用多元逻辑回归来估计过去两年中相对于健康计划和人口统计学因素的乳腺钼靶检查利用率。健康计划的衡量指标包括是否有明确的提供者网络、保险范围是否限于网络内、是否使用看门人制度、成本控制水平、共付额和免赔额金额、 coinsurance rate以及保险福利覆盖范围。

主要发现

在对参加管理式医疗计划与赔偿计划的个体进行二分法比较时,我们发现报告的乳腺钼靶检查利用率没有显著差异。然而,与没有网络的女性相比,参加有明确提供者网络的健康计划的女性在过去两年中更有可能报告接受过乳腺钼靶检查(调整后的OR = 1.21,95%置信区间 = 1.07 - 1.36),并且参加看门人制度计划的女性比没有看门人制度的女性更有可能报告接受过乳腺钼靶检查(调整后的OR = 1.18,95%置信区间 = 1.03 - 1.36)。网络外保险范围受限、成本控制的使用、参保人的费用分担以及保险福利覆盖范围似乎并未影响乳腺钼靶检查的使用。

结论

重要的是要研究个体健康计划组成部分对医疗保健利用的影响,而不是使用传统的更宽泛的管理式医疗与非管理式医疗分类或简单的健康计划类型。